K********g
发帖数: 9389 | |
y*****l
发帖数: 5997 | 2 The market is at the edge to break up. Take some profit if u got lot, else
hold. |
K********g
发帖数: 9389 | 3 好，拿到20快再卖
【在 y*****l 的大作中提到】
: The market is at the edge to break up. Take some profit if u got lot, else
: hold.
|
y*****l
发帖数: 5997 | |
v**********m
发帖数: 5516 | 5 let's roll.
【在 K********g 的大作中提到】
: 纠结中，奶奶的
|
w*********7
发帖数: 2883 | |
y*****l
发帖数: 5997 | |
t**u
发帖数: 1572 | 8 when is the FDA decision?
The big market is more likely to go to south instead of north.
【在 K********g 的大作中提到】
: 纠结中，奶奶的
|
X*****s
发帖数: 2767 | 9 after you sell it, then short it immediately |
y*****l
发帖数: 5997 | 10 16.5还没突破，分批卖吧。下一步17.5。
【在 K********g 的大作中提到】
: 好，拿到20快再卖
|
|
|
K********g
发帖数: 9389 | 11 既然要到17.5，为何要卖？
【在 y*****l 的大作中提到】
: 16.5还没突破，分批卖吧。下一步17.5。
|
y*****l
发帖数: 5997 | 12 16.5破了以后到17.5，现在还没破呢，有可能回调到15.5啊。
【在 K********g 的大作中提到】
: 既然要到17.5，为何要卖？
|
M***y
发帖数: 1594 | |
K********g
发帖数: 9389 | |
f**********g
发帖数: 2252 | 15 买了点，支持牛哥。
【在 K********g 的大作中提到】
: DIP来了，你敢买么？
|
K********g
发帖数: 9389 | 16 看来你真买到Dip了，前途光明？
【在 f**********g 的大作中提到】
: 买了点，支持牛哥。
|
f**********g
发帖数: 2252 | 17 过两天就涨上去了。15买，16.5卖也不错，10%。
【在 K********g 的大作中提到】
: 看来你真买到Dip了，前途光明？
|
f**********g
发帖数: 2252 | 18 8 High Growth Biotech Stocks Being Bought By Hedge Funds
http://finviz.com/screener.ashx?v=341&t=AMRS,CDXS,EXAS,INCY,PAC
http://seekingalpha.com/article/299037-8-high-growth-biotech-st
7. Incyte Corporation (INCY): Focuses on the discovery and development of
proprietary small molecule drugs for hematologic and oncology indications,
and inflammatory and autoimmune diseases. Market cap of $2.06B. Estimated
EPS growth over the next 5 years at 25.0%. Net institutional shares
purchased over the current quarter at 5.8M, which is 4.65% of the company's
124.76M share float. This is a risky stock that is significantly more
volatile than the overall market (beta = 2.42). The stock is a short squeeze
candidate, with a short float at 13.9% (equivalent to 10.59 days of average
volume). The stock has had a couple of great days, gaining 20.67% over the
last week.
【在 K********g 的大作中提到】
: 看来你真买到Dip了，前途光明？
|
f**********g
发帖数: 2252 | 19 12/3 FDA Ruxolitinib for Myelofibrosis
老牛玩 Pre-FDA?
【在 K********g 的大作中提到】
: 看来你真买到Dip了，前途光明？
|
K********g
发帖数: 9389 | 20 For sure
【在 f**********g 的大作中提到】
: 12/3 FDA Ruxolitinib for Myelofibrosis
: 老牛玩 Pre-FDA?
|
|
|
f**********g
发帖数: 2252 | 21 几成把握？可以买点option.
【在 K********g 的大作中提到】
: For sure
|
y*****l
发帖数: 5997 | 22 INCY今天真弱，弹起来又下去了，扶不起来。
【在 K********g 的大作中提到】
: 纠结中，奶奶的
|
M***y
发帖数: 1594 | 23 一早设得14.51, 没买着
收盘时忘了它
现在看着GAP DOWN, 没主意了 |
f**********g
发帖数: 2252 | 24 Got it? 14.5.
【在 M***y 的大作中提到】
: 一早设得14.51, 没买着
: 收盘时忘了它
: 现在看着GAP DOWN, 没主意了
|
v**********m
发帖数: 5516 | 25 现在好股票这么便宜，做pre-run不太划算，损失机会成本。
【在 K********g 的大作中提到】
: For sure
|
f**********g
发帖数: 2252 | 26 Yes, kind of waste time and may miss many good chances.
【在 v**********m 的大作中提到】
: 现在好股票这么便宜，做pre-run不太划算，损失机会成本。
|
M***y
发帖数: 1594 | 27 不喜欢GAP DOWN的,今天没设买单
I'll pass this one.
【在 f**********g 的大作中提到】
: Got it? 14.5.
|
K********g
发帖数: 9389 | 28 好股票是便宜哦，但是还会更便宜哦。
市场下周估计还要够淫荡
【在 v**********m 的大作中提到】
: 现在好股票这么便宜，做pre-run不太划算，损失机会成本。
|
f**********g
发帖数: 2252 | 29 What do u think? Next Monday down, Tues up?
AAPL IBM INTC vs C WFC BAC
17 IBM C WFC GCI HAL SWK
18 AAPL INTC KO BAC EMC JNPR ISRG
【在 K********g 的大作中提到】
: 好股票是便宜哦，但是还会更便宜哦。
: 市场下周估计还要够淫荡
|
K********g
发帖数: 9389 | 30 科技股拉不起来的，银行估计很糟糕，JPM都不行，估计没有好的。
另外欧洲问题还要一个接一个来，还没完全解决。
【在 f**********g 的大作中提到】
: What do u think? Next Monday down, Tues up?
: AAPL IBM INTC vs C WFC BAC
: 17 IBM C WFC GCI HAL SWK
: 18 AAPL INTC KO BAC EMC JNPR ISRG
|
|
|
K********g
发帖数: 9389 | 31 Want to buy another 1K.
【在 K********g 的大作中提到】
: 纠结中，奶奶的
|
f**********g
发帖数: 2252 | 32 Buy some China Concepts.
【在 K********g 的大作中提到】
: 科技股拉不起来的，银行估计很糟糕，JPM都不行，估计没有好的。
: 另外欧洲问题还要一个接一个来，还没完全解决。
|
w*********7
发帖数: 2883 | |
K********g
发帖数: 9389 | 34 不买，很容易被逼成神经颠
【在 f**********g 的大作中提到】
: Buy some China Concepts.
|
w*********7
发帖数: 2883 | 35 re
【在 K********g 的大作中提到】
: 不买，很容易被逼成神经颠
|
f**********g
发帖数: 2252 | 36 SPX 1220 has resistence.
GS C BAC WFC ER next week, may have correction.
Will reduce some positions today.
【在 K********g 的大作中提到】
: 科技股拉不起来的，银行估计很糟糕，JPM都不行，估计没有好的。
: 另外欧洲问题还要一个接一个来，还没完全解决。
|
M***y
发帖数: 1594 | |
f**********g
发帖数: 2252 | 38 Good buy.
【在 M***y 的大作中提到】
: got some @13.99
|
y*****l
发帖数: 5997 | 39 KeepBuying AD, bottom now.
http://finviz.com/screener.ashx?v=341&t=INCY
【在 K********g 的大作中提到】
: 不买，很容易被逼成神经颠
|
K********g
发帖数: 9389 | 40 哈哈哈，上马金么？
【在 y*****l 的大作中提到】
: KeepBuying AD, bottom now.
: http://finviz.com/screener.ashx?v=341&t=INCY
|
|
|
y*****l
发帖数: 5997 | 41 12:55 [Comment From Ira P Ira P : ]
Any thoughts on $INCY December 3 PDUFA?
Thursday October 20, 2011 12:55 Ira P
12:55 adam feuerstein: why isn't FDA convening an advisory panel to review
INCY's drug? Seems weird to me.
12:56 [Comment From Ira P Ira P : ]
Could no panel for $INCY be a positive?
Thursday October 20, 2011 12:56 Ira P
12:58 adam feuerstein: absolutely. it could mean FDA has no issues with
ruxo... to me, it just seems like FDA would hold a panel.
it's been pointed out to me recently that FDA did not hold panels for JNJ's
Zytiga or Roche's melanoma drug (the name escapes me here)
so maybe it's not unusual for FDA to skip panels. |
w*********7
发帖数: 2883 | 42 Earnings Preview: Incyte's Quarterly Results Will Be Reported in 3 Days (
INCY)
Financial News Network Online - Earnings Preview
Incyte (NASDAQ:INCY) is expected by analyst consensus to report a loss of $0
.43 per share on sales of $16.5 million on Thursday. Analysts also expect
losses of $1.49 per share for the current full-year period. Incyte reported
a loss of $0.26 per share a year ago, on sales of $16.9 million. In the
previous quarter, the company reported losses of $0.41 per share, missing
consensus estimates for a loss of $0.36.
Incyte has overhead space with shares priced $14.32, or 35.6% below the
average consensus analyst price target of $22.25. The stock should find
initial resistance at its 50-day moving average (MA) of $14.80 and further
resistance at its 200-day MA of $16.21.
Over the past year, Incyte has traded in a range of $12.58 to $21.15 and is
now at $14.32, 14% above that low. Over the past week, the 200-day moving
average (MA) has gone down 0.4% while the 50-day MA has advanced 0.2%.
Incyte Corporation is using its expertise in genomics and medicinal
chemistry, as well as molecular, cellular, and in vivo biology to discover
and develop novel therapeutics. The Company has drug discovery programs
underway focused on the identification of new small molecule drugs for
cancer and inflammation. |
